Diabetic kidney disease (DKD) is the single most common cause of renal failure in adults starting renal replacement therapy in the UK (UK Renal Registry, 2020). A recent UK national diabetes audit reported that 42.3% of people living with T2D and 32.4% with T1D also had a diagnosis of renal disease (Hill et al, 2014). Moreover, the presence of diabetes worsens all CKD outcomes. The leading cause of death in individuals with an eGFR<60 mL/min remains cardiovascular disease, regardless of the presence of T2D. This session will cover the diagnosis & classification of CKD, delaying the progression of CKD and when to refer. Furthermore, HbA1c targets in DKD will be covered as well as the use of SGLT2 inhibitors for CKD with and without diabetes

• Key take-home messages for primary care from the recently updated NICE CKD guideline updated August 2021
• Key take-home messages for primary care from the KDIGO: diabetes management in CKD guideline published 2020
• Top tips & pitfalls to avoid when interpreting eGFR & urinary ACR